摘要
目的 探讨pipeline栓塞装置(PED)治疗大脑中动脉(MCA)动脉瘤的临床效果。方法 回顾性分析2014年11月至2019年10月我国14个临床中心采用PED治疗的33例MCA动脉瘤的临床资料、影像学资料和随访资料。结果 33例共39个动脉瘤,使用37个PED。33例完成临床随访,30例(36个动脉瘤)完成影像随访;随访时间4~22个月,平均(10.6±6.3)个月;动脉瘤完全或近全闭塞30个(83.3%,30/36);相对于单纯PED治疗组(71.4%),PED辅助弹簧圈栓塞组动脉瘤闭塞率更高(100%;P=0.031);预后不良(m RS评分>2分)3例(9.1%),预后良好(mRS评分≤2分)30例(90.9%);术后并发症发生率为24.2%(8/33),术前规律服用双抗药物3 d以上病人术后并发症发生率明显低于未规律服用双抗药物的病人(P=0.033)。结论 MCA动脉瘤可以采用PED治疗,疗效较满意。对于直径大、形态不规则的MCA动脉瘤,可使用PED结合弹簧圈栓塞治疗以获得更高的闭塞率。术前、术后应规范应用双抗药物以减少缺血、出血并发症。
Objective To investigate the clinical efficacy of pipeline embolization devices(PED)for patients with middle cerebral artery(MCA)aneurysms.Methods The clinical data,imaging data and follow-up data of 33 patients with MCA aneurysms treated with PED in 14 clinical centers from November 2014 to October 2019 were retrospectively analyzed.Results Thirty-seven PEDs were used in 33 patients with 39 MCA aneurysms.Clinical follow-up was completed in 33 patients and imaging follow-up was completed in 30 patients(36 aneurysms).The follow-up time ranged from 4 to 22 months,with an average of(10.6±6.3)months.Complete or near complete occlusion of aneurysms were achieved in 30 aneurysms(83.3%,30/36).Compared with the patients treated with PED alone[71.4%(15/21)],the occlusion rate of aneurysms was significantly higher in the patients treated with PED-assisted coil embolization[100%(15/15);P=0.031].Thirty patients(90.9%)had good prognoses(mRS score≤2),and 3(9.1%)had poor prognoses(mRS score>2).The incidence of postoperative complications was 24.2%(8/33),and patients who received dual antiplatelet therapy for more than 3 days before surgery had a significantly lower incidence of postoperative complications(3.4%)compared to those who did not(50%;P=0.033).Conclusions MCA aneurysms can be treated with PED and the effectiveness is good.For MCA aneurysms with large diameter and irregular morphology,PED combined with coil embolization can obtain a higher occlusion rate.Preoperative and postoperative dual antiplatelet therapies are recommended to decrease ischemia and bleeding complications.
作者
张莹
罗斌
康慧斌
刘健
张义森
杨新健
张鸿祺
李天晓
买买提力·艾沙
毛国华
宋冬雷
王云彦
冯文峰
汪阳
史怀璋
万杰清
刘建民
管生
赵元立
王超
ZHANG Ying;LUO Bin;KANG Hui-bin;LIU Jian;ZHANG Yi-sen;YANG Xin-jian;ZHANG Hong-qi;LI Tian-xiao;MAIMAITILI Aisha;MAO Guo-hua;SONG Dong-lei;WANG Yun-yan;FENG Wen-feng;WANG Yang;SHI Huai-zhang;WAN Jie qing;LIU Jian-min;GUAN Sheng;ZHAO Yuan-li;WANG Chao(Department of Interventional Neuroradiology,Beijing Neurosurgical Institute&Department of Neurosurgery,Beijing Tiantan Hospital,Capital Medical University,Beijing 100070,China;Department of Neurosurgery,Peking University International Hospital,Beijing 102200,China;Department of Neurosurgery,Nanfang Hospital,Southern Medical University,Guangzhou 510515,China;Department of Neurosurgery,Xuanwu Hospital,Capital Medical University,Beijing 100053,China;Department of Interventional Radiology,Henan Provincial People's Hospital,Zhengzhou 450003,China;Department of Neurosurgery,The First Affiliated Hospital of Xinjiang Medical University,Urumqi 841100,China;Department of Neurosurgery,The Second Affiliated Hospital of Nanchang University,Nanchang 330006,China;Department of Neurosurgery,Shanghai Donglei Brain Hospital,Shanghai 201799,China;Department of Neurosurgery,Qilu Hospital,Shandong University,Jinan 250012,China;Department of Neurosurgery,The First Affiliated Hospital of Nanchang University,Nanchang 330006,China;Department of Neurosurgery,The First Affiliated Hospital of Harbin Medical University,Harbin 150000,China;Department of Neurosurgery,Renji Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai 200120,China;Department of Neurosurgery,The First Affiliated Hospital of Naval Medical University,Shanghai 200433,China;Department of Interventional Neuroradiology,The First Affiliated Hospital of Zhengzhou University,Zhengzhou 450052,China)
出处
《中国临床神经外科杂志》
2023年第4期225-229,共5页
Chinese Journal of Clinical Neurosurgery
基金
国家自然科学基金(82072036,82272092)
首发重点攻关项目(2022-1-2041)
北京市医院管理中心登峰人才计划(DFL20220504)。